Results 131 to 140 of about 29,187 (219)

Advising on Antidepressant Use in Pregnancy: Are We All on the Same Page?

Asia-Pacific Psychiatry, Volume 18, Issue 3, September 2026.
ABSTRACT Purpose Perinatal mood disorders are associated with adverse maternal and neonatal outcomes and affect 15%–20% of pregnant people. Guidelines recommend SSRIs when non‐pharmacological therapies are ineffective, yet antenatal depression remains undertreated.
Lucy Charlotte Broughton, Natalie Hughes, Jiaxu Zeng, Alesha Smith   +3 more
wiley   +1 more source

sertraline effect on major depressive disorder

, 2019
For the paper 'Spontaneous thought-related network connectivity predicts sertraline effect on major depressive ...
tw70455@gmail.com tw70455@gmail.com (6704489)
core   +1 more source

Selective Serotonin Reuptake Inhibitor Treatment in Adolescence and Subsequent Risk of Nonaffective Psychosis: A Quasi‐Experimental Study

Acta Psychiatrica Scandinavica, Volume 154, Issue 2, Page 153-162, August 2026.
ABSTRACT Objective Psychotic disorders are frequently preceded by common mental disorders (CMDs), like depression and anxiety. It remains unclear whether treating CMDs in adolescence can reduce subsequent psychosis risk. We applied quasi‐experimental methods to national register data to assess whether a causal relationship exists between selective ...
Ioanna Kougianou, Animesh Talukder, Kirstie O′ Hare, Colm Healy, Ian Kelleher   +4 more
wiley   +1 more source

Ocrelizumab‐induced colitis: VigiBase disproportionality analysis, case reports and literature review

British Journal of Clinical Pharmacology, Volume 92, Issue 7, Page 2162-2170, July 2026.
Aims Ocrelizumab is a humanized anti‐CD20 monoclonal antibody used in multiple sclerosis. Since its commercialization, several cases of ocrelizumab‐induced colitis have been reported in the scientific literature. Methods To explore the potential association of ocrelizumab with colitis as an adverse drug reaction (ADR), we conducted a descriptive and ...
Audrey Fresse, Christophe Hommel, Nadine Petitpain, Philippe Kerschen   +3 more
wiley   +1 more source

Sertraline and inflammatory markers in major depression: a systematic review and meta-analysis

Annals of General Psychiatry
Background Increasing evidence suggests a link between major depressive disorder (MDD) and inflammatory pathways. Sertraline, a commonly used selective serotonin reuptake inhibitor (SSRI), may influence inflammatory cytokine levels.
ZiLiang Xie, Zheng Gao, Xue Li, Shuo Li, Fan Tang, Caiyi Zhang   +5 more
doaj   +1 more source

A population pharmacokinetic model for sertraline in women during the perinatal period-A contribution from the ConcePTION project. [PDF]

AIMS Sertraline is frequently prescribed for mental health conditions in both pregnant and breastfeeding women. According to the limited available data, only small amounts of sertraline are transferred into human milk, yet with a large amount of ...
Hascoët, Jean-Michel, Harari, Mathilde, Morisod, Guidi, M., Cardoso, E., Weisskopf, Etienne, Gandia, P., Csajka, C., Epiney, Manuella, Crettol, Severine, Eap, Chin B, Crettol, S., Fischer Fumeaux, Céline J., Ferreira, E., Leclair, G., Fischer Fumeaux, C.J., Allegaert, Karel; id_orcid, Eap, C.B., Graz, Myriam Bickle, Monfort, A., Guidi, Monia, Graz, Myriam, Bickle, Graz, M.B., Nordeng, H., Eap, Chin, B, Eap, Chin B., Harari, Mathilde Morisod, Epiney, M., Harari, M.M., Nordeng, Hedvig, Cardoso, Evelina, Ansermot, Nicolas, Hascoët, J.M., Claris, O., Csajka, Chantal, Annaert, Pieter, Annaert, P., Panchaud, Alice, Ansermot, N., Weisskopf, E., Allegaert, K., Claris, Olivier, Fischer Fumeaux, Céline J, Fischer Fumeaux, Céline, J, Ferreira, Ema, Hascoët, Jean Michel, Gandia, Peggy, Panchaud, A., Leclair, Grégoire, Allegaert, Karel, Monfort, Anaëlle   +49 more
core   +1 more source

Postherpetic Neuralgia: Mechanisms, Risk Factors, and Stratified Management—A Narrative Review

CNS Neuroscience &Therapeutics, Volume 32, Issue 7, July 2026.
The incidence of PHN is increasing, posing a substantial public health burden. Its pathogenesis involves VZV reactivation, peripheral and central sensitization, and genetic susceptibility, with key risk factors including older age, severe acute pain, extensive rash, immunocompromise, comorbidities, and delayed treatment.
Fei Tang, Fukun Zhao
wiley   +1 more source

Sertraline: A New Specific Serotonin Reuptake Blocker

, 1991
Sertraline hydrochloride is a new naphthylamino compound that specifically blocks neuronal reuptake of serotonin. It is currently available in the United Kingdom and under review in the US.
Sally K. Guthrie
core   +1 more source

Seladelpar Improved Itch, Itch‐Related Sleep Disturbance and Measures of Fatigue in Patients With Primary Biliary Cholangitis and Pruritus in the Phase 3 RESPONSE Trial

Alimentary Pharmacology &Therapeutics, Volume 64, Issue 1, Page 23-35, July 2026.
Seladelpar improved itch, itch‐related sleep disturbance and measures of fatigue in patients with primary biliary cholangitis and pruritus in the Phase 3 RESPONSE trial. ABSTRACT Background Pruritus and fatigue impose a significant burden on patient quality of life in primary biliary cholangitis (PBC).
Cynthia Levy, David E. J. Jones, Marlyn J. Mayo, Christopher L. Bowlus, Kris V. Kowdley, Gideon M. Hirschfield, Jie Liu, Caroline Burk, Susheela Carroll, Daria B. Crittenden, Andreas E. Kremer   +10 more
wiley   +1 more source

The PREDEP-SERT study protocol: A 6-month follow-up cohort study of predictors of effectiveness, tolerability and safety of sertraline for depression using Therapeutic Drug Monitoring.

PLoS ONE
Sertraline is a common first-line pharmacological treatment of Major Depressive Disorder (MDD). There is no established consensus nor clinical guidelines for personalized dose adjustments, which imply risks of toxicity and lack of efficacy.
Patricio Molero, Covadonga Canga-Espina, Begoña Tapia-Alzuguren, José Pablo Bullard, María Del Mar Unceta-González, Enrique Aubá, Jorge M Núñez-Córdoba, Felipe Ortuño, Azucena Aldaz   +8 more
doaj   +1 more source